Actemra Disease-Modifying Antirheumatic Agent Tocilizumab, Preservative Free 162 mg / 0.9 mL Subcutaneous Injection Prefilled Syringe , 0.9 mL Genentech 50242013801

Actemra Disease-Modifying Antirheumatic Agent Tocilizumab, Preservative Free 162 mg / 0.9 mL Subcutaneous Injection Prefilled Syringe , 0.9 mL Genentech 50242013801

1- REGULATIONS ON PURCHASE OF THESE PRODUCTS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE. 2-THESE ITEMS WOULD BE USED ONLY BY QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , HEALTH CARE PROVIDERS , .... ) WITH VALID PROFESSIONAL LICENSE. 3- ANY INQUIRY REGARDING THESE ITEMS WOULD BE PROCESSED AFTER VERIFICATION OF VALID LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )

Manufacturer # 50242013801 Brand Actemra® Manufacturer Genentech USA Application Disease-Modifying Antirheumatic Agent Container Type Prefilled Syringe Dosage Form Injection Generic Drug Code 35486 Generic Drug Name Tocilizumab, Preservative Free NDC Number 50242-0138-01 Strength 162 mg / 0.9 mL Type Subcutaneous Volume 0.9 mL

Features

ACTEMRA (tocilizumab) is a recombinant humanized anti-human interleukin 6 (IL-6) receptor monoclonal antibody of the immunoglobulin IgG1? (gamma 1, kappa) subclass with a typical H2L2 polypeptide structure ACTEMRA solution for subcutaneous administration is supplied as a sterile, colorless to yellowish, preservative-free liquid solution of approximately pH 6.0 It is supplied in a 1 mL ready-to-use, single-use prefilled syringe (PFS) with a needle safety device Each device delivers 0.9 mL (162 mg) of ACTEMRA, in a histidine buffered solution composed of ACTEMRA (180 mg/mL), polysorbate 80, L-histidine and L-histidine monohydrochloride, L-arginine and L-arginine hydrochloride, L-methionine, and water for injection